In adults with T2D, HFpEF, and HbA1c above target despite triple therapy (metformin, SGLT2i, and GLP-1 RA), adding IBT MAY BE CONSIDERED to improve glycemic control. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.